Similar articles for PMID: 422961

Year	Number of Results
1976	3
1977	4
1978	9
1979	4
1980	4
1981	7
1982	5
1983	7
1984	5
1985	10
1986	5
1987	10
1988	4
1989	8
1990	10
1991	4
1992	4
1993	6
1994	3
1995	1
1996	1
1997	3
1998	3
1999	2
2000	1
2002	3
2003	2
2005	1
2009	1
2013	1
2015	1
2016	1
2019	1
2024	0

1

Long-term treatment of Parkinson's disease with bromocriptine.

Rascol A, Guiraud B, Montastruc JL, David J, Clanet M. Rascol A, et al. J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):143-50. doi: 10.1136/jnnp.42.2.143. J Neurol Neurosurg Psychiatry. 1979. PMID: 422961 Free PMC article.

2

Optimum symptomatic control of Parkinson's disease with dopaminergic therapy.

Bouchard S. Bouchard S. Can J Neurol Sci. 1987 Aug;14(3 Suppl):460-5. doi: 10.1017/s0317167100037926. Can J Neurol Sci. 1987. PMID: 3676921

3

Early institution of bromocriptine in Parkinson's disease inhibits the emergence of levodopa-associated motor side effects. Long-term results of the PRADO study.

Przuntek H, Welzel D, Gerlach M, Blümner E, Danielczyk W, Kaiser HJ, Kraus PH, Letzel H, Riederer P, Uberla K. Przuntek H, et al. J Neural Transm (Vienna). 1996;103(6):699-715. doi: 10.1007/BF01271230. J Neural Transm (Vienna). 1996. PMID: 8836932 Clinical Trial.

4

Should dopamine agonists be given early or late in the treatment of Parkinson's disease?

Rascol A, Montastruc JL, Rascol O. Rascol A, et al. Can J Neurol Sci. 1984 Feb;11(1 Suppl):229-32. doi: 10.1017/s0317167100046461. Can J Neurol Sci. 1984. PMID: 6713321

5

Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.

[No authors listed] [No authors listed] BMJ. 1993 Aug 21;307(6902):469-72. doi: 10.1136/bmj.307.6902.469. BMJ. 1993. PMID: 8400928 Free PMC article. Clinical Trial.

6

Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.

Grimes JD, Delgado MR. Grimes JD, et al. Clin Neuropharmacol. 1985;8(1):73-7. Clin Neuropharmacol. 1985. PMID: 3978651

7

Treatment of parkinson's disease with bromocriptine.

Lieberman A, Kupersmith M, Estey E, Goldstein M. Lieberman A, et al. N Engl J Med. 1976 Dec 16;295(25):1400-4. doi: 10.1056/NEJM197612162952504. N Engl J Med. 1976. PMID: 989885

8

[Bromocriptine as the 1st treatment of Parkinson's disease. Long term results].

Rascol A, Montastruc JL, Guiraud-Chaumeil B, Clanet M. Rascol A, et al. Rev Neurol (Paris). 1982;138(5):401-8. Rev Neurol (Paris). 1982. PMID: 7146724 French.

9

[Bromocriptine in Parkinsonian syndromes. Results obtained in a group of patients treated for 8 months].

Quattrini A, Paggi A, Del Pesce M, Di Bella P. Quattrini A, et al. Riv Patol Nerv Ment. 1978 May-Jun;99(3):150-63. Riv Patol Nerv Ment. 1978. PMID: 752907 Italian.

10

Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.

Ogawa N, Kanazawa I, Kowa H, Kuno S, Mizuno Y, Tashiro K, Yanagisawa N. Ogawa N, et al. Eur Neurol. 1997;38 Suppl 2:37-49. doi: 10.1159/000113482. Eur Neurol. 1997. PMID: 9387802 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

133 results

Results by year